Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BG Thiazolidinediones
A10BG02 Rosiglitazone
D00596 Rosiglitazone maleate (JAN/USP)
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Agents
Thiazolidinedione
Rosiglitazone
D00596 Rosiglitazone maleate (JAN/USP)
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione
DG00116 Rosiglitazone
D00596 Rosiglitazone maleate
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione
DG00116 Rosiglitazone
D00596 Rosiglitazone maleate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D00596 Rosiglitazone maleate (JAN/USP)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00596
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00596
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione
DG00116 Rosiglitazone
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione
DG00116 Rosiglitazone